| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |